Publication:
Paulomycin G, a New Natural Product with Cytotoxic Activity against Tumor Cell Lines Produced by Deep-Sea Sediment Derived Micromonospora matsumotoense M-412 from the Aviles Canyon in the Cantabrian Sea

dc.contributor.authorSarmiento-Vizcaino, Aida
dc.contributor.authorBrana, Alfredo F.
dc.contributor.authorPerez-Victoria, Ignacio
dc.contributor.authorMartin, Jesus
dc.contributor.authorde Pedro, Nuria
dc.contributor.authorde la Cruz, Mercedes
dc.contributor.authorDiaz, Caridad
dc.contributor.authorVicente, Francisca
dc.contributor.authorAcuna, Jose L.
dc.contributor.authorReyes, Fernando
dc.contributor.authorGarcia, Luis A.
dc.contributor.authorBlanco, Gloria
dc.contributor.authoraffiliation[Sarmiento-Vizcaino, Aida] Univ Oviedo, Dept Biol Func, Area Microbiol, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Brana, Alfredo F.] Univ Oviedo, Dept Biol Func, Area Microbiol, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Blanco, Gloria] Univ Oviedo, Dept Biol Func, Area Microbiol, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Sarmiento-Vizcaino, Aida] Univ Oviedo, Inst Univ Oncol Principado Asturias, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Brana, Alfredo F.] Univ Oviedo, Inst Univ Oncol Principado Asturias, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Blanco, Gloria] Univ Oviedo, Inst Univ Oncol Principado Asturias, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Perez-Victoria, Ignacio] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[Martin, Jesus] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[de Pedro, Nuria] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[de la Cruz, Mercedes] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[Diaz, Caridad] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[Vicente, Francisca] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[Reyes, Fernando] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain
dc.contributor.authoraffiliation[Acuna, Jose L.] Univ Oviedo, Area Ecol, Dept Biol Organismos & Sistemas, E-33006 Oviedo, Spain
dc.contributor.authoraffiliation[Garcia, Luis A.] Univ Oviedo, Area Ingn Quim, Dept Ingn Quim & Tecnol Medio Ambiente, E-33006 Oviedo, Spain
dc.contributor.funderGobierno del Principado de Asturias
dc.contributor.funderMinisterio de Ciencia e Innovacion
dc.date.accessioned2023-02-12T02:23:06Z
dc.date.available2023-02-12T02:23:06Z
dc.date.issued2017-09-01
dc.description.abstractThe present article describes a structurally novel natural product of the paulomycin family, designated as paulomycin G (1), obtained from the marine strain Micromonospora matsumotoense M-412, isolated from Cantabrian Sea sediments collected at 2000 m depth during an oceanographic expedition to the submarine Avils Canyon. Paulomycin G is structurally unique since-to our knowledge-it is the first member of the paulomycin family of antibiotics lacking the paulomycose moiety. It is also the smallest bioactive paulomycin reported. Its structure was determined using HRMS and 1D and 2D NMR spectroscopy. This novel natural product displays strong cytotoxic activities against different human tumour cell lines, such as pancreatic adenocarcinoma (MiaPaca2), breast adenocarcinoma (MCF-7), and hepatocellular carcinoma (HepG2). The compound did not show any significant bioactivity when tested against a panel of bacterial and fungal pathogens.
dc.identifier.doi10.3390/md15090271
dc.identifier.essn1660-3397
dc.identifier.unpaywallURLhttps://www.mdpi.com/1660-3397/15/9/271/pdf?version=1503894727
dc.identifier.urihttp://hdl.handle.net/10668/19300
dc.identifier.wosID411559800010
dc.issue.number9
dc.journal.titleMarine drugs
dc.journal.titleabbreviationMar. drugs
dc.language.isoen
dc.organizationFundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía)
dc.organizationFundación MEDINA
dc.publisherMdpi
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectpaulomycins
dc.subjectMicromonospora
dc.subjectantitumor
dc.subjectCantabrian Sea-derived actinobacteria
dc.subjectStreptomyces-albus
dc.subjectStrategies
dc.subjectAntitumor
dc.subjectSponge
dc.titlePaulomycin G, a New Natural Product with Cytotoxic Activity against Tumor Cell Lines Produced by Deep-Sea Sediment Derived Micromonospora matsumotoense M-412 from the Aviles Canyon in the Cantabrian Sea
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number15
dc.wostypeArticle
dspace.entity.typePublication

Files